RxDoctor Payments Data

Casey Ward, PA

Physician Assistant · Asheville, NCNPI 1174063382

Payments from drug & device makers

$1,860in general payments, 2019–2025

Across 82 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$366
  • Gilead$300
  • Indivior Inc.$221
  • Alkermes, Inc.$199
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$192
  • Lilly USA, LLC$186
  • plus $396 from 13 others

What the payments were for

  • Food & beverage$1,81197%
  • Education$493%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,860 in reported general payments places this provider in the 80th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$2,316
Medicare patients
23
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$16,526
Combivent RespimatIpratropium/Albuterol Sulfate11$8,520
SymbicortBudesonide/Formoterol Fumarate15$4,113
Pantoprazole Sodium19$2,174
Albuterol Sulfate HfaAlbuterol Sulfate22$779
Rosuvastatin Calcium49$403
Famotidine18$365
Omeprazole23$326
Bupropion XlBupropion Hcl15$315
Gabapentin14$270
Cyclobenzaprine Hcl13$252
Atorvastatin Calcium39$238
Trazodone Hcl18$238
Lisinopril38$234
Levothyroxine Sodium18$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$16,52618 claims
AstraZenecaSymbicort$125$4,11315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →